https://tarianpharma.com/preclinical-program-in-two-species-completed/ 2026-10-12T07:19:35+00:00 https://tarianpharma.com/first-gmp-batches-of-tarian-gel-manufactured/ 2026-10-12T07:18:50+00:00 https://tarianpharma.com/first-fundraising-closed/ 2026-10-12T07:18:06+00:00 https://tarianpharma.com/approval-of-first-proof-of-concept-study-in-the-prevention-of-egfri/ 2026-10-12T07:17:22+00:00 https://tarianpharma.com/submission-of-second-proof-of-concept/ 2026-10-12T07:16:23+00:00 https://tarianpharma.com/approval-study-inneuropathy/ 2026-10-12T07:15:31+00:00 https://tarianpharma.com/second-fundraising-closed/ 2026-10-12T07:14:03+00:00 https://tarianpharma.com/czernielewski-j-winckle-g-andres-p-a-new-extended-release-topical-formulation-of-brimonidine-tartrate/ 2026-09-29T07:19:17+00:00 https://tarianpharma.com/wp-content/uploads/2026/09/EADV-09-2025-poster-scaled.jpg https://tarianpharma.com/attendance-of-the-mascc-congress-in-seattle/ 2026-09-21T14:06:40+00:00 https://tarianpharma.com/wp-content/uploads/2025/06/6f1e807a4a88de7f7430fb695769de9025f06e7a-scaled.jpg https://tarianpharma.com/advances-clinical-program-toward-2026/ 2026-09-15T11:13:46+00:00 https://tarianpharma.com/wp-content/uploads/2025/12/01.png https://tarianpharma.com/wp-content/uploads/2025/12/02.png https://tarianpharma.com/wp-content/uploads/2025/12/03.png https://tarianpharma.com/wp-content/uploads/2025/12/04.png https://tarianpharma.com/wp-content/uploads/2025/12/05-1.png https://tarianpharma.com/results-of-dose-regimen-study-in-healthy-volunteers/ 2025-06-23T09:37:10+00:00 https://tarianpharma.com/results-of-21-day-local-tolerance-and-pk-study-in-healthy-volunteers/ 2025-06-23T09:37:02+00:00